Brain Serotonin and 5-hydroxyindoleacetic Acid Concentrations and Serotonin Synthesis Following Tetrahydro-beta-carboline Administration in Mice

Overview

Journal Naunyn Schmiedebergs Arch Pharmacol

Specialty Pharmacology

Date 1980 Nov 1

PMID 6164934

Citations 2

Authors

N S Buckholtz

Affiliations

Soon will be listed here.

Citing Articles

Selective MAO-B inhibitors: a lesson from natural products.

Carradori S, DAscenzio M, Chimenti P, Secci D, Bolasco A Mol Divers. 2013; 18(1):219-43.

PMID: 24218136 DOI: 10.1007/s11030-013-9490-6.

5-HT, dopamine, norepinephrine, and related metabolites in brain of low alcohol drinking (LAD) rats shift after chronic intra-hippocampal infusion of harman.

Adell A, Myers R Neurochem Res. 1995; 20(2):209-15.

PMID: 7540261 DOI: 10.1007/BF00970546.

References

Fuller R, Perry K, Molloy B . Effect of an uptake inhibitor on serotonin metabolism in rat brain: studies with 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine (Lilly 110140). Life Sci. 1974; 15(6):1161-71. DOI: 10.1016/s0024-3205(74)80012-3. View

Carlsson A, Lindqvist M . In-vivo measurements of tryptophan and tyrosine hydroxylase activities in mouse brain. J Neural Transm. 1973; 34(2):79-91. DOI: 10.1007/BF01244661. View

Rommelspacher H, Subramanian N . Tetrahydronorharmane modulates the depolarisation-induced efflux of 5-hydroxytryptamine and dopamine and is released by high potassium concentration from rat brain slices. Eur J Pharmacol. 1979; 56(1-2):81-6. DOI: 10.1016/0014-2999(79)90436-9. View

Sparks D, Buckholtz N . 6-Methoxy-1,2,3,4-tetrahydro-beta-carboline: a specific monoamine oxidase-A inhibitor in CF-1 mouse brain. Neurosci Lett. 1980; 20(1):73-8. DOI: 10.1016/0304-3940(80)90236-0. View

Barker S, Harrison R, Brown G, Christian S . Gas chromatographic/mass spectrometric evidence for the identification of 1,2,3,4-tetrahydro-beta-carboline as an in vivo constituent of rat brain. Biochem Biophys Res Commun. 1979; 87(1):146-54. DOI: 10.1016/0006-291x(79)91659-0. View

Meller E, Friedman E, Schweitzer J, Friedhoff A . Tetrahydro-beta-carbolines: specific inhibitors of type A monoamine oxidase in rat brain. J Neurochem. 1977; 28(5):995-1000. DOI: 10.1111/j.1471-4159.1977.tb10661.x. View

Jacoby J, Howd R, Levin M, Wurtman R . Mechanisms by which quipazine, a putative serotonin receptor agonist, alters brain 5-hydroxyindole metabolism. Neuropharmacology. 1976; 15(9):529-34. DOI: 10.1016/0028-3908(76)90103-9. View

Karasawa T, Nakamura I, Shimizu M . Simultaneous microdetermination of homovanillic acid and 5-hydroxyindoleacetic acid in brain tissue using Sephadex G-10 and QAE-Sephadex A-25. Life Sci. 1974; 15(8):1465-74. DOI: 10.1016/0024-3205(74)90121-0. View

Atack C, Magnusson T . A procedure for the isolation of noradrenaline (together with adrenaline), dopamine, 5-hydroxytryptamine and histamine from the same tissue sample using a single column of strongly acidic cation exchange resin. Acta Pharmacol Toxicol (Copenh). 1978; 42(1):35-57. DOI: 10.1111/j.1600-0773.1978.tb02168.x. View

10.

Ho B, Taylor D, Walker K, McISAAC W . The mode of action of 6-methoxy-1,2,3,4-tetrahydro- -carboline on brain serotonin. Can J Biochem. 1973; 51(4):482-5. DOI: 10.1139/o73-057. View

11.

Tachiki K, Aprison M . Fluorometric assay for 5-hydroxytryptophan with sensitivity in the picomole range. Anal Chem. 1975; 47(1):7-11. DOI: 10.1021/ac60351a004. View

12.

Thomas T, Buckholtz N, ZEMP J . 6-Methoxyl-1,2,3,4-tetrahydro-beta-carboline effects on retinal serotonin. Life Sci. 1979; 25(16):1435-41. DOI: 10.1016/0024-3205(79)90421-1. View

13.

Fuller R, Hemrick S, Mills J . Inhibition of monoamine oxidase by N-phenacyl-cyclopropylamine. Biochem Pharmacol. 1978; 27(18):2255-61. DOI: 10.1016/0006-2952(78)90085-0. View

14.

Carlsson A, Lindqvist M . The effect of L-tryptophan and some psychotropic drugs on the formation of 5-hydroxytryptophan in the mouse brain in vivo. J Neural Transm. 1972; 33(1):23-43. DOI: 10.1007/BF01244726. View

15.

Carlsson A, Lindqvist M . Effects of antidepressant agents on the synthesis of brain monoamines. J Neural Transm. 1978; 43(2):73-91. DOI: 10.1007/BF01579067. View

16.

Halaris A, Lovell R, Freedman D . Effect of chlorimipramine on the metabolism of 5-hydroxytryptamine in the rat brain. Biochem Pharmacol. 1973; 22(17):2200-2. DOI: 10.1016/0006-2952(73)90120-2. View

17.

Neff N, Yang H, Fuentes J . The use of selective monoamine oxidase inhibitor drugs to modify amine metabolism in brain. Adv Biochem Psychopharmacol. 1974; 12(0):49-57. View

18.

ROSECRANS J, Lovell R, Freedman D . Effects of lysergic acid diethylamide on the metabolism of brain 5-hydroxytryptamine. Biochem Pharmacol. 1967; 16(10):2011-21. DOI: 10.1016/0006-2952(67)90313-9. View

19.

Rommelspacher H, Strauss S, Cohnitz C . Inhibition of 5-hydroxytryptamine uptake by tetrahydronorharmane in vivo. Naunyn Schmiedebergs Arch Pharmacol. 1978; 303(3):229-33. DOI: 10.1007/BF00498048. View

20.

Ho B, McISAAC W, Walker K, Estevez V . Inhibitors of monoamine oxidase. Influence of methyl substitution on the inhibitory activity of beta-carbolines. J Pharm Sci. 1968; 57(2):269-74. DOI: 10.1002/jps.2600570205. View